BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 20206259)

  • 41. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
    Bujalska IJ; Draper N; Michailidou Z; Tomlinson JW; White PC; Chapman KE; Walker EA; Stewart PM
    J Mol Endocrinol; 2005 Jun; 34(3):675-84. PubMed ID: 15956339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 11beta-hydroxysteroid dehydrogenase type 1 of the subcutaneous adipose tissue is dysregulated but not associated with metabolic disorders in adults born small for gestational age.
    Meas T; Carreira E; Wang Y; Rauh M; Poitou C; Clément K; Dötsch J; Lévy-Marchal C
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3949-54. PubMed ID: 20519348
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women.
    Veilleux A; Blouin K; Rhéaume C; Daris M; Marette A; Tchernof A
    Metabolism; 2009 May; 58(5):624-31. PubMed ID: 19375584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
    Tagawa N; Kubota S; Kobayashi Y; Kato I
    Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H6PDH interacts directly with 11beta-HSD1: implications for determining the directionality of glucocorticoid catalysis.
    Zhang YL; Zhong X; Gjoka Z; Li Y; Stochaj W; Stahl M; Kriz R; Tobin JF; Erbe D; Suri V
    Arch Biochem Biophys; 2009 Mar; 483(1):45-54. PubMed ID: 19121282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
    Baudrand R; Carvajal CA; Riquelme A; Morales M; Solis N; Pizarro M; Escalona A; Boza C; Pérez G; Domínguez A; Arrese M; Fardella CE
    Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat.
    Bujalska IJ; Durrani OM; Abbott J; Onyimba CU; Khosla P; Moosavi AH; Reuser TT; Stewart PM; Tomlinson JW; Walker EA; Rauz S
    J Endocrinol; 2007 Feb; 192(2):279-88. PubMed ID: 17283228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes.
    Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women.
    Blouin K; Blanchette S; Richard C; Dupont P; Luu-The V; Tchernof A
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E398-404. PubMed ID: 15494612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study.
    Paulmyer-Lacroix O; Boullu S; Oliver C; Alessi MC; Grino M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2701-5. PubMed ID: 12050237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Saturated fatty acids in human visceral adipose tissue are associated with increased 11- β-hydroxysteroid-dehydrogenase type 1 expression.
    Petrus P; Rosqvist F; Edholm D; Mejhert N; Arner P; Dahlman I; Rydén M; Sundbom M; Risérus U
    Lipids Health Dis; 2015 May; 14():42. PubMed ID: 25934644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice.
    Wang J; Wang Y; Liu L; Lutfy K; Friedman TC; Liu Y; Jiang M; Liu Y
    Clin Sci (Lond); 2019 Nov; 133(21):2189-2202. PubMed ID: 31696216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.
    Yan C; Yang H; Wang Y; Dong Y; Yu F; Wu Y; Wang W; Adaku U; Lutfy K; Friedman TC; Tian S; Liu Y
    Int J Obes (Lond); 2016 Aug; 40(8):1233-41. PubMed ID: 27102048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome.
    Mariniello B; Ronconi V; Rilli S; Bernante P; Boscaro M; Mantero F; Giacchetti G
    Eur J Endocrinol; 2006 Sep; 155(3):435-41. PubMed ID: 16914598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs.
    Sieber-Ruckstuhl NS; Meli ML; Boretti FS; Gönczi E; Lutz H; Reusch CE
    Horm Metab Res; 2007 Aug; 39(8):548-54. PubMed ID: 17712718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
    Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
    Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice.
    Wang Y; Liu L; Du H; Nagaoka Y; Fan W; Lutfy K; Friedman TC; Jiang M; Liu Y
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E543-51. PubMed ID: 24381005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mediastinal adipose tissue expresses a pathogenic profile of 11 β-hydroxysteroid dehydrogenase Type 1, glucocorticoid receptor, and CD68 in patients with coronary artery disease.
    Atalar F; Gormez S; Caynak B; Akan G; Tanriverdi G; Bilgic-Gazioglu S; Gunay D; Duran C; Akpinar B; Ozbek U; Buyukdevrim AS; Yazıcı Z
    Cardiovasc Pathol; 2013; 22(3):183-8. PubMed ID: 22955009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.